Cargando…

Transient hypoalgesia after COVID-19 infection

INTRODUCTION: Loss of smell or taste are often-cited complications during COVID-19 disease, but there is no clear evidence for affection of the peripheral nervous system. METHODS: Here, we report a 48-year-old man presenting with persistent dysgeusia and hypoalgesia of the lower legs, hands, and che...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Juliane, Papagianni, Aikaterini, Herrmann, Eva, Nöller, Frank, Sommer, Claudia, Rittner, Heike L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920299/
https://www.ncbi.nlm.nih.gov/pubmed/35295965
http://dx.doi.org/10.1097/PR9.0000000000000990
_version_ 1784669098597154816
author Becker, Juliane
Papagianni, Aikaterini
Herrmann, Eva
Nöller, Frank
Sommer, Claudia
Rittner, Heike L.
author_facet Becker, Juliane
Papagianni, Aikaterini
Herrmann, Eva
Nöller, Frank
Sommer, Claudia
Rittner, Heike L.
author_sort Becker, Juliane
collection PubMed
description INTRODUCTION: Loss of smell or taste are often-cited complications during COVID-19 disease, but there is no clear evidence for affection of the peripheral nervous system. METHODS: Here, we report a 48-year-old man presenting with persistent dysgeusia and hypoalgesia of the lower legs, hands, and cheeks after COVID-19 infection in Spring 2020. RESULTS: Upon clinical examination 7 months after the infection, the patient could not feel pain after pinprick stimuli. Quantitative sensory testing revealed increased thermal detection thresholds at the face but no changes at the foot. Electrical C-fiber stimulation elicited lower pain ratings at the distal leg compared with the proximal leg, but overall higher pain ratings than in healthy control subjects. The axon flare reaction in response to histamine and acetylcholine was almost absent with no pain sensation. Skin punch biopsy revealed a reduced intraepidermal nerve fiber density at the lower leg, and transient receptor potential vanilloid 1 and calcitonin gene-related peptide immunoreactivity were similar to a healthy control. Symptoms and positive tests improved 5 months later. CONCLUSION: In summary, we describe a case of hypoalgesia after COVID-19 disease. Studies investigating long-COVID syndrome should test not only for painful neuropathic symptoms but also for hypoalgesia, especially in patients with prolonged dysgeusia.
format Online
Article
Text
id pubmed-8920299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-89202992022-03-15 Transient hypoalgesia after COVID-19 infection Becker, Juliane Papagianni, Aikaterini Herrmann, Eva Nöller, Frank Sommer, Claudia Rittner, Heike L. Pain Rep COVID-19 and pain INTRODUCTION: Loss of smell or taste are often-cited complications during COVID-19 disease, but there is no clear evidence for affection of the peripheral nervous system. METHODS: Here, we report a 48-year-old man presenting with persistent dysgeusia and hypoalgesia of the lower legs, hands, and cheeks after COVID-19 infection in Spring 2020. RESULTS: Upon clinical examination 7 months after the infection, the patient could not feel pain after pinprick stimuli. Quantitative sensory testing revealed increased thermal detection thresholds at the face but no changes at the foot. Electrical C-fiber stimulation elicited lower pain ratings at the distal leg compared with the proximal leg, but overall higher pain ratings than in healthy control subjects. The axon flare reaction in response to histamine and acetylcholine was almost absent with no pain sensation. Skin punch biopsy revealed a reduced intraepidermal nerve fiber density at the lower leg, and transient receptor potential vanilloid 1 and calcitonin gene-related peptide immunoreactivity were similar to a healthy control. Symptoms and positive tests improved 5 months later. CONCLUSION: In summary, we describe a case of hypoalgesia after COVID-19 disease. Studies investigating long-COVID syndrome should test not only for painful neuropathic symptoms but also for hypoalgesia, especially in patients with prolonged dysgeusia. Wolters Kluwer 2022-03-11 /pmc/articles/PMC8920299/ /pubmed/35295965 http://dx.doi.org/10.1097/PR9.0000000000000990 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License 4.0 (CC BY-NC-SA) (https://creativecommons.org/licenses/by-nc-sa/4.0/) which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle COVID-19 and pain
Becker, Juliane
Papagianni, Aikaterini
Herrmann, Eva
Nöller, Frank
Sommer, Claudia
Rittner, Heike L.
Transient hypoalgesia after COVID-19 infection
title Transient hypoalgesia after COVID-19 infection
title_full Transient hypoalgesia after COVID-19 infection
title_fullStr Transient hypoalgesia after COVID-19 infection
title_full_unstemmed Transient hypoalgesia after COVID-19 infection
title_short Transient hypoalgesia after COVID-19 infection
title_sort transient hypoalgesia after covid-19 infection
topic COVID-19 and pain
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920299/
https://www.ncbi.nlm.nih.gov/pubmed/35295965
http://dx.doi.org/10.1097/PR9.0000000000000990
work_keys_str_mv AT beckerjuliane transienthypoalgesiaaftercovid19infection
AT papagianniaikaterini transienthypoalgesiaaftercovid19infection
AT herrmanneva transienthypoalgesiaaftercovid19infection
AT nollerfrank transienthypoalgesiaaftercovid19infection
AT sommerclaudia transienthypoalgesiaaftercovid19infection
AT rittnerheikel transienthypoalgesiaaftercovid19infection